FdaApplication
ANDA 216250
Identifiers
- fda_app_no: ANDA216250
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2022-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 4% | SOLUTION;TOPICAL |
1 product